Regenerex Pharma (RGPX) Cash from Investing Activities (2011 - 2023)

Regenerex Pharma (RGPX) reported Cash from Investing Activities of -$2670.0 for Q3 2023, up 26.43% quarter-over-quarter from -$3629.0 in Q2 2023.

Regenerex Pharma (RGPX) Cash from Investing Activities (2011 - 2023) Analysis & Trends

Regenerex Pharma (RGPX) has 4 years of Cash from Investing Activities data on file, last reported at -$2670.0 in Q3 2023.

Cash from Investing Activities for Q3 2023 came in at -$2670.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was -$6299.0 (down 109.97% YoY), and the FY2025 annual result was -$1228.0, up 80.5% from the prior year.
Cash from Investing Activities advanced to -$2670.0 in Q3 2023 per RGPX's latest filing, from -$3629.0 in the prior quarter.
Over five years, Cash from Investing Activities peaked at -$2670.0 in Q3 2023 and troughed at -$3629.0 in Q2 2023.

Download Data